Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver Metastases

Clinical trial NCT06023173 · COMPLETED

Trial details

NCT number: NCT06023173
Sponsor: Fudan University
Status: COMPLETED
Study type: OBSERVATIONAL

The Patients With CRLM Who Benefit More From Bevacizumab

Start date: 2013-10-01
Primary completion: 2023-01-01
Enrollment: 307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.